A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults

BACKGROUND: Cannabis use disorder (CUD) is a prevalent and impairing condition, and established psychosocial treatments convey limited efficacy. In light of recent findings supporting the efficacy of N-acetylcysteine (NAC) for CUD in adolescents, the objective of this trial was to evaluate its effic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Drug Alcohol Depend
Main Authors: Gray, Kevin M., Sonne, Susan C., McClure, Erin A., Ghitza, Udi E., Matthews, Abigail G., McRae-Clark, Aimee L., Carroll, Kathleen M., Potter, Jennifer S., Wiest, Katharina, Mooney, Larissa J., Hasson, Albert, Walsh, Sharon L., Lofwall, Michelle R., Babalonis, Shanna, Lindblad, Robert W., Sparenborg, Steven, Wahle, Aimee, King, Jacqueline S., Baker, Nathaniel L., Tomko, Rachel L., Haynes, Louise F., Vandrey, Ryan G., Levin, Frances R.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5535813/
https://ncbi.nlm.nih.gov/pubmed/28623823
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugalcdep.2017.04.020
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados